Thesis Investigation of an ME/CFS-associated Mutation in the Transmembrane PRR L-SIGN and Its Effect on Infection and Phagocytosis, 2024, Schwarz

Discussion in 'ME/CFS research' started by forestglip, Jan 27, 2025.

  1. forestglip

    forestglip Senior Member (Voting Rights)

    Messages:
    1,430
    Investigation of an ME/CFS-associated Mutation in the Transmembrane PRR L-SIGN and Its Effect on Infection and Phagocytosis

    Michael Schwarz

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multisystemic
    disease that affects millions of people across the globe. It is characterized by a variety
    of debilitating symptoms such as post-exertional malaise, brain fog, extreme fatigue, and many others that are shared by a variety of illnesses. In conjunction with the overlap in symptoms, a lack of consistency across studies and lack of unique diagnostic biomarkers has left ME/CFS poorly understood with a lack of detailed mechanistic studies.

    A single nucleotide polymorphism, denoted rs479448, in the CLEC4M gene that encodes the C-type lectin L-SIGN has been associated with ME/CFS in a genome-wide association study (GWAS). The aim of the study described here was to test the hypothesis that the CLEC4M mutation causes cells to become more pro-inflammatory, more easily infected by pathogens recognized by L-SIGN, and, in the case of macrophages more efficient at phagocytosing pathogens. To this end, we used epifluorescence microscopy and live cell imaging to analyze cells transfected with both the mutant and wild-type variants of CLEC4M, with regard to their response to Candida albicans infection.

    Our study establishes the groundwork for testing the phagocytosis efficiency of macrophages expressing the ME/CFS-associated variant of CLEC4M, which could lead to an exacerbation of the pro-inflammatory response. Additional work will need to be conducted in order to determine statistical significance of these findings, but the preliminary data proves promising.

    Link (Thesis) [Paywall]
     
    Yann04, Peter Trewhitt and obeat like this.
  2. Peter Trewhitt

    Peter Trewhitt Senior Member (Voting Rights)

    Messages:
    4,486
    Is it normal for a master’s thesis to be behind a paywall?
     
    Jaybee00 and Yann04 like this.
  3. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    347
    Location:
    Norway
    No, mine is free and public (from Norway). His is from the US, so I guess everything goes there.
     
    EndME, Peter Trewhitt and Yann04 like this.
  4. Yann04

    Yann04 Senior Member (Voting Rights)

    Messages:
    1,416
    Location:
    Romandie (Switzerland)
    Anyone know what GWAS they are talking about?
     
    Peter Trewhitt likes this.
  5. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    347
    Location:
    Norway
  6. Jonathan Edwards

    Jonathan Edwards Senior Member (Voting Rights)

    Messages:
    16,006
    Location:
    London, UK
    This is the study with 40 ME/CFS cases I think - which seems unlikely to be reliable evidence for a link. The investigation of the mutation does not seem to have come to any great conclusion?
     
    Peter Trewhitt and Yann04 like this.
  7. Midnattsol

    Midnattsol Moderator Staff Member

    Messages:
    3,861
    One of mine, that used data from a clinical trial, is not even published on the university’s own library pages as the chief investigator who owns the data had not published their findings. For the other the thesis is available from the university, but the scientific article is behind paywall at the journal. The thesis was not available until the article was published.
     
  8. forestglip

    forestglip Senior Member (Voting Rights)

    Messages:
    1,430
    The study says this:
    The supplementary table says:
    36 controls and 20 ME/CFS have TT
    2 controls and 22 ME/CFS have CT
     
    MeSci, Peter Trewhitt and Yann04 like this.
  9. Yann04

    Yann04 Senior Member (Voting Rights)

    Messages:
    1,416
    Location:
    Romandie (Switzerland)
    That’s interesting, so if this study was well done it’s present in ~50% of pwME but just ~5% of controls.
     
    Peter Trewhitt likes this.
  10. Jonathan Edwards

    Jonathan Edwards Senior Member (Voting Rights)

    Messages:
    16,006
    Location:
    London, UK
    Yes, but they rolled the dice a million times.
     
    Utsikt, Yann04 and Peter Trewhitt like this.
  11. Yann04

    Yann04 Senior Member (Voting Rights)

    Messages:
    1,416
    Location:
    Romandie (Switzerland)
    Is there a way we can cross check it with healthy controls in another study to see if the percentages are similar?
    I know that doesn’t discount random error making the share of pwME having the mutation seem large, but it does potentially make the found proportion of HC with it more or less reliable if replicated.
     
    Last edited: Jan 27, 2025
    Peter Trewhitt likes this.
  12. forestglip

    forestglip Senior Member (Voting Rights)

    Messages:
    1,430
    Someone please correct me if I'm misunderstanding something.

    The paper gives the alleles on the negative strand. The corresponding alleles on the positive strand, which dbSNP uses, are T->A and C->G.

    According to dbSNP, globally, G (C on the negative strand above) is rare.

    A=0.991286 G=0.008714 (n=231456)

    African ancestry looks a bit higher at about 15% for the G allele.
     
    Peter Trewhitt and Yann04 like this.
  13. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    347
    Location:
    Norway
    Peter Trewhitt likes this.
  14. Jonathan Edwards

    Jonathan Edwards Senior Member (Voting Rights)

    Messages:
    16,006
    Location:
    London, UK
    I may have misremembered but I think we had looked at this study and somebody did try to check it with another cohort and it didn't pan out.
     
    EndME, Peter Trewhitt and Yann04 like this.
  15. forestglip

    forestglip Senior Member (Voting Rights)

    Messages:
    1,430
    I don't see any search results in the forum other than this thread for "CLEC4M", "L-SIGN" (had to use Google for this one because the minus sign messes up results), "CD299", or "rs479448".

    This thread might be what you're remembering, though I don't think this SNP was one that was cross-referenced with the UK Biobank. I don't get any results for the thread's SNP.
     
    EndME and Peter Trewhitt like this.
  16. forestglip

    forestglip Senior Member (Voting Rights)

    Messages:
    1,430
    Just wondering why studies don't do something like this to increase statistical power:

    It seems in a genetic study, for controls, you could use numbers from the huge GWAS studies that have been done on the general population. While some of the "controls" will be ME/CFS, you could estimate the prevalence to get the extreme possibilities for what non-ME/CFS was for the SNP.

    So say you want to use a large GWAS as the controls for a given SNP. The GWAS says 99% of people have TT and 1% have CT.

    You use an estimate for ME/CFS in the studied population, maybe 0.5%. (A range could also be used for prevalence.) You consider the two extreme possibilities as the range for SNP prevalence:
    • 100% of the 1% of people who have CT were non-ME/CFS.
      • So if 99.5% of the population are non-ME/CFS, that means 98.5/99.5=98.99% of non-ME/CFS have TT and the rest, 1.01% have CT.
    • All those with ME/CFS have CT.
      • That leaves 0.5% of the non-ME/CFS with CT. 99/99.5=99.5% of non-ME/CFS have TT and the rest, 0.5% have CT.
    So instead of a control group of 38 people, you'd have a control group with 200,000 people, where you can test the significance using the most extreme scenario where 1.01% of people without ME/CFS have CT.

    Some people in the GWAS will be CC which will complicate things, but I'm sure that could also be incorporated in the range.

    There's less of a need to perfectly match the two groups for environment in a genetic study. They could make an attempt to use similar ancestry, though.
     
    Last edited: Jan 27, 2025
    Yann04 and Peter Trewhitt like this.
  17. Jonathan Edwards

    Jonathan Edwards Senior Member (Voting Rights)

    Messages:
    16,006
    Location:
    London, UK
    I think that is what was done with the Leeds UK Biobank data, with 2000 ME/CFS cases and probably 20,000 controls. If I remember rightly it did not confirm any prior suggested links, although that may not have been specifically published. DecodeME was set up on the basis that even with 2000 probands no very obvious gene linkages were found. That makes it hard to see why nothing further has been said about this 2016 study if the results are robust.

    I am pretty sure somebody else knows more about this than I do. @Andy?
     
    Peter Trewhitt, Yann04 and EndME like this.
  18. forestglip

    forestglip Senior Member (Voting Rights)

    Messages:
    1,430
    I don't know what the first sentence means so maybe you could explain if it's relevant for this SNP. But it seems like this SNP wasn't tested in the BioBank since it's not coming up in the results.
     
    Peter Trewhitt and Yann04 like this.

Share This Page